![David Scott Geyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de David Scott Geyer
Anciens postes connus de David Scott Geyer
Sociétés | Poste | Début | Fin |
---|---|---|---|
TRF Pharma, Inc.
![]() TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology TRF Pharma, Inc. develops pharmaceutical products. It specializes in the fields of hematology and oncology. The firm's services include developing therapies to treat diseases related to aberrant cell adhesion and endothelial walls. The company was founded by Stephen H. Embury and Neil Matsui in 2002 and is headquartered in Burlingame, CA. | Directeur Technique/Scientifique/R&D | 01/04/2009 | - |
Corporate Officer/Principal | 01/12/2008 | 01/04/2009 | |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/02/2004 | 01/02/2004 |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
Protein Design Labs, Inc.
![]() Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Directeur Technique/Scientifique/R&D | - | 10/01/2011 |
Corporate Officer/Principal | 10/01/2011 | - | |
Ares-Serono Group
![]() Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador. | Corporate Officer/Principal | - | - |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | Directeur Technique/Scientifique/R&D | 16/06/2010 | 10/01/2011 |
Corporate Officer/Principal | 10/01/2011 | - | |
LADRX CORPORATION | Corporate Officer/Principal | 21/12/2009 | - |
Formation de David Scott Geyer
Texas A&M University | Graduate Degree |
University of Louisiana at Lafayette | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Suisse | 2 |
Opérationnelle
Corporate Officer/Principal | 7 |
Chief Tech/Sci/R&D Officer | 3 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 8 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
LADRX CORPORATION | Health Technology |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | Health Technology |
TRF Pharma, Inc.
![]() TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology TRF Pharma, Inc. develops pharmaceutical products. It specializes in the fields of hematology and oncology. The firm's services include developing therapies to treat diseases related to aberrant cell adhesion and endothelial walls. The company was founded by Stephen H. Embury and Neil Matsui in 2002 and is headquartered in Burlingame, CA. | Health Technology |
Ares-Serono Group
![]() Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador. | Health Technology |
Protein Design Labs, Inc.
![]() Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Bourse
- Insiders
- David Scott Geyer
- Expérience